Cases 31 - 40 of 84
Biogen International GmbH v. Amneal Pharmaceuticals LLC
as 21-1078
Defendant / Appellee:
SANDOZ INC., S&B PHARMA, INC., GRAVITI PHARMACEUTICALS PVT. LTD. and others
Plaintiff / Appellant:
BIOGEN INTERNATIONAL GMBH and BIOGEN MA INC.
Pfizer Inc. et al v. Cipla, Ltd. et al
as 1:2020cv01393
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Defendant:
Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Jacksonville Police Officers and Fire Fighters Health Insurance Trust v. Gilead Sciences, Inc. et al
as 4:2020cv06522
Defendant:
Gilead Sciences, Inc., Cipla Ltd and Cipla USA Inc.
Plaintiff:
Jacksonville Police Officers and Fire Fighters Health Insurance Trust
Cause Of Action: 28 U.S.C. § 1337
Biogen International GmbH v. Cipla Limited
as 21-1092
Plaintiff / Appellant:
BIOGEN MA INC. and BIOGEN INTERNATIONAL GMBH
Defendant / Appellee:
CIPLA USA INC. and CIPLA LIMITED
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Cipla Limited et al
as 1:2020cv00977
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. CIPLA Limited
as 20-1875
Defendant / Appellant:
CIPLA USA, INC. and CIPLA LIMITED
Plaintiff / Appellee:
ONYX THERAPEUTICS, INC.
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
